• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

费城染色体白血病中的复杂染色体易位。连续易位还是协同基因组重排?

Complex chromosomal translocations in the Philadelphia chromosome leukemias. Serial translocations or a concerted genomic rearrangement?

作者信息

Fitzgerald P H, Morris C M

机构信息

Cytogenetic and Molecular Oncology Unit, Christchurch School of Medicine, New Zealand.

出版信息

Cancer Genet Cytogenet. 1991 Dec;57(2):143-51. doi: 10.1016/0165-4608(91)90145-k.

DOI:10.1016/0165-4608(91)90145-k
PMID:1756491
Abstract

Joining of the BCR and ABL genes is an essential feature of the group of human leukemias characterized by the Philadelphia chromosome and there is recent evidence that the human BCR-ABL fusion gene induces leukemia in experimental animals. Joining of these two genes is the result of cytogenetic translocation, usually the t(9;22)(q34;q11), but sometimes of more complex translocations involving one or more chromosomes in addition to chromosomes 9 and 22. The leukemic cells of some patients carry the BCR-ABL fusion gene but have an apparently normal karyotype. Recent studies show that these cells conceal complex chromosome rearrangements. Because the BCR-ABL fusion gene appears to be the result of cytogenetic rearrangement in all cases of these leukemias, the causes and mechanism of chromosome rearrangement will be relevant to the development of leukemia in man. We examine mechanisms of chromosome rearrangement and propose that both simple and complex chromosome translocations result from a single, though sometimes complex, interchange event.

摘要

BCR基因与ABL基因的融合是具有费城染色体的一组人类白血病的基本特征,并且最近有证据表明人类BCR-ABL融合基因在实验动物中可诱发白血病。这两个基因的融合是细胞遗传学易位的结果,通常是t(9;22)(q34;q11),但有时是更复杂的易位,除了9号和22号染色体外还涉及一条或多条染色体。一些患者的白血病细胞携带BCR-ABL融合基因,但核型明显正常。最近的研究表明,这些细胞隐藏着复杂的染色体重排。由于在所有这些白血病病例中,BCR-ABL融合基因似乎都是细胞遗传学重排的结果,因此染色体重排的原因和机制将与人类白血病的发生发展相关。我们研究了染色体重排的机制,并提出简单和复杂的染色体易位均源于单一的,尽管有时是复杂的交换事件。

相似文献

1
Complex chromosomal translocations in the Philadelphia chromosome leukemias. Serial translocations or a concerted genomic rearrangement?费城染色体白血病中的复杂染色体易位。连续易位还是协同基因组重排?
Cancer Genet Cytogenet. 1991 Dec;57(2):143-51. doi: 10.1016/0165-4608(91)90145-k.
2
Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemias with rearrangements in the BCR gene first intron: further evidence implicating Alu sequences in the chromosome translocation.Ph1阳性急性白血病中BCR和ABL基因的结构改变,BCR基因第一内含子发生重排:Alu序列参与染色体易位的进一步证据
Nucleic Acids Res. 1989 Oct 11;17(19):7631-42. doi: 10.1093/nar/17.19.7631.
3
Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.慢性髓性白血病(CML)中一种变异的费城染色体1易位t(9;22;11) (q34;q11;q13)的分子特征显示,BCR基因的3'端部分易位至染色体带11q13。 1 费城染色体(Philadelphia chromosome,Ph)是一种特异性染色体异常,在慢性髓性白血病中常见。
Oncogene. 1993 Dec;8(12):3239-47.
4
Molecular biology of the Philadelphia positive leukaemias.
Recenti Prog Med. 1989 Oct;80(10):508-19.
5
Philadelphia chromosome-positive chronic myelogenous leukemia with deleted fusion of BCR and ABL genes.伴有BCR和ABL基因缺失融合的费城染色体阳性慢性粒细胞白血病
Jpn J Cancer Res. 1990 Jan;81(1):35-42. doi: 10.1111/j.1349-7006.1990.tb02504.x.
6
Molecular characterization of variant translocations in chronic myelogenous leukemia.慢性粒细胞白血病中变异易位的分子特征
Oncogene. 1989 Sep;4(9):1145-8.
7
A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.在一例慢性髓性白血病患者的费城细胞中发现涉及5号染色体短臂的复杂易位t(5;9;22) 。
J Exp Clin Cancer Res. 2007 Sep;26(3):411-5.
8
Establishment of a cell line with variant BCR/ABL breakpoint expressing P180BCR/ABL from late-appearing Philadelphia-positive acute biphenotypic leukemia.从晚期出现的费城染色体阳性急性双表型白血病中建立表达P180BCR/ABL的具有变异BCR/ABL断点的细胞系。
Genes Chromosomes Cancer. 1998 Nov;23(3):227-38. doi: 10.1002/(sici)1098-2264(199811)23:3<227::aid-gcc4>3.0.co;2-3.
9
Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.abl癌基因的激活及其在人类白血病染色体易位中的作用。
Mutat Res. 1988 May;195(3):231-43. doi: 10.1016/0165-1110(88)90002-4.
10
Chromosomal in situ hybridization and Southern blot analyses using c-abl, c-sis, or bcr probe in chronic myelogenous leukemia cells with variant Philadelphia translocations.
Cancer Genet Cytogenet. 1989 Mar;38(1):61-74. doi: 10.1016/0165-4608(89)90166-0.

引用本文的文献

1
A genetic basis for sex differences in Xp11 translocation renal cell carcinoma.Xp11 易位性肾细胞癌中性别差异的遗传基础。
Cell. 2024 Oct 3;187(20):5735-5752.e25. doi: 10.1016/j.cell.2024.07.038. Epub 2024 Aug 20.
2
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention.初诊时伴有附加遗传学异常的慢性髓性白血病患者在接受积极治疗干预的一线伊马替尼治疗中的影响。
Haematologica. 2023 Sep 1;108(9):2380-2395. doi: 10.3324/haematol.2022.282184.
3
Genomic Mechanisms Influencing Outcome in Chronic Myeloid Leukemia.
影响慢性髓性白血病预后的基因组机制
Cancers (Basel). 2022 Jan 26;14(3):620. doi: 10.3390/cancers14030620.
4
Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis.尼罗替尼用于费城染色体阴性/BCR-ABL阳性慢性期慢性髓性白血病患者的一线治疗:ENEST1st亚组分析
J Cancer Res Clin Oncol. 2017 Jul;143(7):1225-1233. doi: 10.1007/s00432-017-2359-9. Epub 2017 Feb 21.
5
BCR translocation to derivative chromosome 2: a new case of chronic myeloid leukemia with a complex variant translocation and Philadelphia chromosome.BCR基因易位至衍生染色体2:一例伴有复杂变异易位和费城染色体的慢性髓系白血病新病例。
Oncol Lett. 2010 May;1(3):445-447. doi: 10.3892/ol_00000078. Epub 2010 May 1.
6
Complex translocation involving four chromosomes in a novel Philadelphia-positive chronic myeloid leukemia case.1例罕见的费城染色体阳性慢性髓系白血病患者中涉及四条染色体的复杂易位
Oncol Lett. 2011 Mar;2(2):273-276. doi: 10.3892/ol.2011.257. Epub 2011 Jan 21.
7
A novel five-way translocation t(7;11;9;22;9)(q22;q13;q34;q11.2;q34) involving Ph chromosome in a patient of chronic myeloid leukemia: a case report.一名慢性髓性白血病患者中涉及费城染色体的新型五重易位t(7;11;9;22;9)(q22;q13;q34;q11.2;q34):病例报告
Mol Cytogenet. 2012 May 1;5(1):20. doi: 10.1186/1755-8166-5-20.
8
Novel four-way Ph translocation t(9;22;7;1)(q34;q11;q22;p13) in a chronic myeloid leukemia patient receiving tyrosine kinase inhibitor therapy.慢性髓性白血病患者接受酪氨酸激酶抑制剂治疗后出现新型四向 Ph 易位 t(9;22;7;1)(q34;q11;q22;p13)。
Int J Hematol. 2012 Mar;95(3):315-9. doi: 10.1007/s12185-012-1018-9. Epub 2012 Feb 10.
9
Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements.在涉及变异 t(9;22)或其他染色体重排的慢性髓性白血病病例中,断裂点区域的基因组特征呈非随机分布。
Mol Cancer. 2010 May 25;9:120. doi: 10.1186/1476-4598-9-120.
10
Novel complex translocation involving 5 different chromosomes in a chronic myeloid leukemia with Philadelphia chromosome: a case report.费城染色体阳性慢性髓系白血病中涉及5条不同染色体的新型复杂易位:1例报告
Mol Cytogenet. 2009 Nov 9;2:21. doi: 10.1186/1755-8166-2-21.